Blood Flow Restriction Training in Individuals Awaiting Total Knee Replacement

Sponsor
The University of Texas Health Science Center at San Antonio (Other)
Overall Status
Recruiting
CT.gov ID
NCT06111690
Collaborator
National Institute on Aging (NIA) (NIH)
20
1
1
18.3
1.1

Study Details

Study Description

Brief Summary

The aim is to demonstrate that preoperative exercises (prehabilitation) using blood-flow restriction training (BFRT) is safe, well tolerated, improves muscle function, decreases functional limitation, and increases physical activity in older adults awaiting total knee replacement (TKR).

Condition or Disease Intervention/Treatment Phase
  • Procedure: Blood Flow Restriction Training (BFRT)
N/A

Detailed Description

Twenty individuals ≥60 years old awaiting TKR due to diagnosis of end-stage knee osteoarthritis who meet the inclusion/exclusion criteria will be invited to participate in a 6 weeks of low-intensity BFRT prehabilitation. We will assess muscle functional (i.e., cross-sectional area and intramuscular fatty content) using computerized tomography, quadriceps muscle strength using an isokinetic dynamometer, a battery of performance-based physical function, self-reported physical function and quality of life, and biomarkers of inflammation using blood serum. Feasibility assessment will be done by looking at safety (i.e., adverse events), compliance, and attrition rate.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
This is a single group pre-post design studyThis is a single group pre-post design study
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Feasibility of Prehabilitation Blood-flow Restriction Training in Individuals Awaiting Total Knee Replacement.
Actual Study Start Date :
Sep 23, 2022
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Apr 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Preoperative Exercises

Intervention is blood flow restriction training (BFRT)

Procedure: Blood Flow Restriction Training (BFRT)
Participants will be performing low-resistance exercise with (BFRT). Intervention will start at least seven days after initial evaluation, so it does not influence measures of real-time physical activity. We will use a log to register exercise completion and to record bilateral knee pain before, during and after each intervention session
Other Names:
  • BFRT
  • Outcome Measures

    Primary Outcome Measures

    1. Quadricep Muscle Strength [Baseline, 8 weeks and 16 weeks]

      Changes in strength will be measured using an isokinetic dynamometer. Quadriceps femoris maximum voluntary isometric contraction (MVIC) as torque output (Nm) will be measured. Subjects will be seated in the dynamometer's chair with their knee at 60 degrees of flexion.

    2. Thigh muscles composition [Baseline, 8 weeks and 16 weeks]

      Change in thigh muscles % fat-free mass and % fat mass will be measured using a DXA scan.

    3. Thigh muscle volume [Baseline, 8 weeks and 16 weeks]

      Change in thigh muscles cross-sectional area (volume) will be measured using a DXA scan.

    Secondary Outcome Measures

    1. Self-selected Gait Speed [Baseline, 8 weeks and 16 weeks]

      Subject will walk a 4-meter walkway at a self-selected pace. Time to complete task will be recorded.

    2. Timed up and go Test [Baseline, 8 weeks and 16 weeks]

      Subject will get up from a chair, walk 3 meters, turn around and walk back to and sit on the chair. Time to complete task will be recorded.

    3. 30-second chair stand test [Baseline, 8 weeks and 16 weeks]

      Subject will perform sit-to-stand from a standard chair for 30 seconds. Number of times of completed sit-to-stand in 30 seconds will be recorded.

    4. Stair climb test [Baseline, 8 weeks and 16 weeks]

      Subject will climb up and down a flight of stairs (11 steps). Time to complete task will be recorded.

    5. 6-minute Walk Test [Baseline, 8 weeks and 16 weeks]

      Subjects will cover as much as they can while walking on a flat, unobstructed path for 6 minutes.

    6. Patient-Reported Physical Outcome [Baseline, 8 weeks and 16 weeks]

      Patient-Reported Physical Outcome will be assessed using PROMIS® (Patient-Reported Outcomes Measurement Information System), which is used to evaluate and monitor physical, mental, and social health in persons with several conditions.

    7. Health Related Quality of Life (RAND-36) [Baseline, 8 weeks and 16 weeks]

      the RAND-36 Questionnaire is comprised of 36 items that assess eight health concepts: physical functioning, role limitations caused by physical health problems, role limitations caused by emotional problems, social functioning, emotional well-being, energy/fatigue, pain, and general health perceptions.

    8. Real-time Physical Activity [Baseline, 8 weeks and 16 weeks]

      An activity monitor will be worn for 7 days and physical activity (i.e., daily number of steps) will be tracked.

    9. Inflammatory Biomarkers [Baseline, 8 weeks and 16 weeks]

      Change in 'MILLIPLEX® MAP Human High Sensitivity T Cell Magnetic Bead Panel' to assess a panel of 8 inflammatory biomarkers: Interleukin (IL)-1β, IL-2, IL-5, IL-6, IL-10, IL-12p70, IL-13 and Interferon-γ.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    60 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Participants are awaiting primary unilateral TKR due to diagnosis of end-stage KOA. Potential individuals must have at least 8 weeks waiting time in between study baseline assessment and surgery. This 8-week timeframe will allow for completion of baseline (T0) and follow-up assessments (T1: immediately after 6-week prehabilitation program);

    2. are older than 60 years;

    3. speak fluent English to reliably complete the study questionnaires and understand study instructions.

    Exclusion Criteria:
    1. have a history of cardiovascular disease, uncontrolled hypertension (blood pressure ≥140/90 mmHg), deep-vein thrombosis, varicose veins, or rhabdomyolysis;

    2. have absolute contraindications to exercise, as established by the American College of Sports Medicine (uncontrolled arrhythmias, third degree heart block, recent EKG changes, unstable angina, acute myocardial infarction, and acute congestive heart failure);

    3. report of 2 or more falls within the past year;

    4. cannot walk a distance of 100 feet (30.5 meters) without an assistive device or need of a rest period;

    5. have bilateral TKR or undergoing TKR revision or other total joint replacement in the lower extremities; or

    6. have severe visual or hearing impairment. In addition to the affects that these impairments have on safety during participation in the intervention, they may also interfere with data collection (questionnaires and telephone checks);

    7. have a lower extremity amputation;

    8. are unable to comfortably bear weight on the affected knee;

    9. have a BMI above 40.

    10. history of muscular disease (e.g., muscular dystrophy) or neurological disorder that may affect lower extremity function (e.g., cerebrovascular accident, neuropathy, Parkinson's disease, multiple sclerosis);

    11. had additional surgery to the lower extremities within the past 12 months.

    12. a Folstein Mini-Mental State Examination score of <24.

    13. have acute or terminal illness;

    14. are planning to have another TKR (primary on contralateral, or revision on same knee) within 4 months;

    15. are planning to relocate to another city within 4 months.

    16. Subjects with Sickle cell disease

    17. lymphedema or vascular access restrictions

    18. Subjects who have any on-going medical emergency

    19. An ankle-brachial index outside of the expected range 0.9 and 1.3

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 UT Health San Antonio- Dept. of Physical Therapy San Antonio Texas United States 78229

    Sponsors and Collaborators

    • The University of Texas Health Science Center at San Antonio
    • National Institute on Aging (NIA)

    Investigators

    • Principal Investigator: Gustavo Almeida, PhD, The University of Texas Health Science Center at San Antonio

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Gustavo Almeida, Assistant Professor, The University of Texas Health Science Center at San Antonio
    ClinicalTrials.gov Identifier:
    NCT06111690
    Other Study ID Numbers:
    • HSC20210590H
    • 5P30AG044271
    First Posted:
    Nov 1, 2023
    Last Update Posted:
    Nov 1, 2023
    Last Verified:
    Oct 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Gustavo Almeida, Assistant Professor, The University of Texas Health Science Center at San Antonio
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 1, 2023